Product image of Moxifloxacin Ratiopharm (Moxifloxacin) supplied by GNH India

Moxifloxacin Ratiopharm

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacin Ratiopharm (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacin Ratiopharm, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections in adult patients, including respiratory and skin infections.

GNH India supplies Moxifloxacin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxifloxacin is a fluoroquinolone antibacterial indicated for several acute bacterial infections.

  • Community‑acquired pneumonia: effective in treating adult patients with CAP caused by susceptible organisms.
  • Acute bacterial sinusitis: resolves infection and alleviates sinus symptoms.
  • Acute exacerbation of chronic bronchitis: improves respiratory function during COPD flare‑ups.
  • Skin and soft‑tissue infections: treats adult skin infections caused by susceptible bacteria.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these targets, it prevents bacterial DNA supercoiling and separation, leading to inhibition of bacterial cell division and ultimately bacterial death. The drug exhibits concentration‑dependent bactericidal activity against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Side Effects

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Rash: mild skin erythema.
  • Dizziness: occasional vertigo.
  • Abdominal pain: cramp‑like discomfort.

Serious or Rare Side Effects

  • Tendon rupture: sudden tendon pain or swelling, especially in the Achilles.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Clostridioides difficile infection: severe colitis symptoms.
  • Severe allergic reactions: anaphylaxis, angioedema.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.
  • Peripheral neuropathy: numbness or tingling in extremities.

Precautions & Warnings

Before prescribing Moxifloxacin, clinicians should consider several safety factors.

  • Renal impairment: assess kidney function and adjust dose if necessary.
  • Hepatic impairment: monitor liver enzymes and use with caution.
  • QT prolongation: avoid in patients with known cardiac conduction disorders.
  • Tendon disorders: discontinue if tendon pain, swelling, or inflammation occurs.
  • Pregnancy and lactation: safety not established; weigh benefits against potential risks.
  • Store at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Moxifloxacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin.
  • Warfarin: may increase INR and risk of bleeding.
  • QT‑prolonging drugs (e.g., macrolides, antiarrhythmics): heighten risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase CNS side effects.
  • Oral contraceptives: efficacy may be reduced, consider alternative contraception.

Frequently Asked Questions

Moxifloxacin Ratiopharm is prescribed for adult patients with community‑acquired pneumonia, acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and skin or soft‑tissue infections caused by bacteria that are susceptible to fluoroquinolones.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition stops bacterial cells from multiplying, leading to rapid bactericidal activity against a broad range of Gram‑positive and Gram‑negative organisms.

The dosage regimen for Moxifloxacin Ratiopharm is determined by the prescribing clinician based on the infection type, severity, patient age, renal and hepatic function, and local guidelines. Patients should follow the exact instructions provided by their healthcare professional.

Safety data for moxifloxacin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and after careful consideration by the prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers a broader spectrum against Gram‑positive organisms and better activity in respiratory infections compared with older fluoroquinolones such as ciprofloxacin. It also has a once‑daily dosing schedule, but shares class‑related safety considerations like tendon risk and QT prolongation.

Store the tablets at room temperature, below 25 °C, in the original blister pack or container. Keep them away from excess moisture, heat and direct sunlight to maintain product stability.

Moxifloxacin Ratiopharm is taken orally, usually with a full glass of water. It can be taken with or without food, but should not be taken simultaneously with antacids containing aluminum or magnesium, which can impair absorption.

Serious risks include tendon rupture, especially in the Achilles tendon; QT interval prolongation leading to potentially fatal arrhythmias; severe allergic reactions such as anaphylaxis; Clostridioides difficile‑associated colitis; and hepatic injury. Patients should be monitored closely for any of these events.

Moxifloxacin should be avoided in patients with known hypersensitivity to fluoroquinolones, a history of tendon disorders related to quinolone use, significant QT prolongation, or those taking other QT‑prolonging agents without careful monitoring. It is also contraindicated in patients with severe renal or hepatic impairment unless dose adjustments are made.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.